Oh, those leaning towers are so yesterday. Tech-watching sites, rather, are talking about a tower that does not lean; it is just as interesting as it is a self twisting tower. This is the Urbach Tower.
* This article was originally published here
Sunday 16 June 2019
PCSK9 inhibitors: Studies needed to prove efficacy and safety in chronic kidney disease
Chronic kidney disease (CKD) is associated with a substantially increased risk for the development of atherosclerotic cardiovascular disease (CVD). Accordingly, cardiovascular mortality is increased even in the earliest stages of CKD. In the general population and in CKD patients, high plasma levels of low-density lipoprotein cholesterol (LDL-C) are crucially involved in the initiation and progression of atherosclerotic vascular lesions. In addition, it has been documented that LDL accumulating in the vascular wall is prone to be post-translationally modified, for example, by oxidation or carbamylation, which is particularly relevant to patients with CKD.
* This article was originally published here
* This article was originally published here
Black race not tied to worse prostate cancer mortality
(HealthDay)—After adjustment for nonbiological differences, black race is not associated with worse prostate cancer-specific mortality among men with nonmetastatic prostate cancer, according to a study published online May 23 in JAMA Oncology.
* This article was originally published here
* This article was originally published here
Subscribe to:
Posts (Atom)